Home/Filings/4/0001114220-18-000096
4//SEC Filing

Carberry Christine A. 4

Accession 0001114220-18-000096

CIK 0001114220other

Filed

Oct 21, 8:00 PM ET

Accepted

Oct 22, 8:50 AM ET

Size

5.1 KB

Accession

0001114220-18-000096

Insider Transaction Report

Form 4
Period: 2018-10-18
Carberry Christine A.
Chief Operating Officer
Transactions
  • Sale

    Common Stock

    2018-10-18$3.29/sh2,040$6,712111,115 total
Footnotes (2)
  • [F1]Sale of a total of 2,040 shares of common stock was made in order to satisfy Ms. Carberry's income tax withholding obligation upon the vesting of 7,083 shares of restricted stock on October 17, 2018. Ms. Carberry had no discretion with respect to such sale, which was transacted in accordance with the Issuer's corporate policies regarding the vesting of restricted stock.
  • [F2]Includes 76,665 shares of restricted stock.

Issuer

KERYX BIOPHARMACEUTICALS INC

CIK 0001114220

Entity typeother

Related Parties

1
  • filerCIK 0001694459

Filing Metadata

Form type
4
Filed
Oct 21, 8:00 PM ET
Accepted
Oct 22, 8:50 AM ET
Size
5.1 KB